88 related articles for article (PubMed ID: 7742194)
1. Arterial thrombosis after chemotherapy with cisplatin, vinblastine and methotrexate.
Molloy RG; Welch GC; Drury JK; Abel BJ
Br J Clin Pract; 1995; 49(1):50-1. PubMed ID: 7742194
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of methotrexate, vinblastine, doxorubicin, and cisplatin in patients with squamous cell carcinoma of the upper respiratory or alimentary passages of the head and neck.
Okuno SH; Mailliard JA; Suman VJ; Edmonson JH; Creagan ET; Nair S; Levitt R; Kugler JW
Cancer; 2002 Apr; 94(8):2224-31. PubMed ID: 12001121
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy of cisplatin, methotrexate, vinblastine, and high-dose tamoxifen for transitional cell carcinoma.
Hsu CH; Chen J; Wu CY; Cheng AL; Pu YS
Anticancer Res; 2001; 21(1B):711-5. PubMed ID: 11299831
[TBL] [Abstract][Full Text] [Related]
4. Drug related genetic polymorphisms affecting adverse reactions to methotrexate, vinblastine, doxorubicin and cisplatin in patients with urothelial cancer.
Tsuchiya N; Inoue T; Narita S; Kumazawa T; Saito M; Obara T; Tsuruta H; Horikawa Y; Yuasa T; Satoh S; Habuchi T
J Urol; 2008 Dec; 180(6):2389-95. PubMed ID: 18930278
[TBL] [Abstract][Full Text] [Related]
5. Can patient selection for bladder preservation be based on response to chemotherapy?
Sternberg CN; Pansadoro V; Calabrò F; Schnetzer S; Giannarelli D; Emiliozzi P; De Paula F; Scarpone P; De Carli P; Pizzo M; Platania A; Amini M
Cancer; 2003 Apr; 97(7):1644-52. PubMed ID: 12655521
[TBL] [Abstract][Full Text] [Related]
6. Acute Arterial Thrombosis during Postoperative Adjuvant Cisplatin-based Chemotherapy for Completely Resected Lung Adenocarcinoma.
Sato C; Okuda K; Tamiya H; Yamamoto K; Hoshina K; Narumoto O; Urushiyama H; Noguchi S; Amano Y; Watanabe K; Mitani A; Kage H; Tanaka G; Yamauchi Y; Takai D; Nagase T
Intern Med; 2018 Feb; 57(4):557-561. PubMed ID: 29225246
[TBL] [Abstract][Full Text] [Related]
7. Clinical results and quality of life analysis for the MVAC combination (methotrexate, vinblastine, doxorubicin, and cisplatin) in carcinoma of the uterine cervix: A Gynecologic Oncology Group study.
Long HJ; Monk BJ; Huang HQ; Grendys EC; McMeekin DS; Sorosky J; Miller DS; Eaton LA; Fiorica JV;
Gynecol Oncol; 2006 Mar; 100(3):537-43. PubMed ID: 16216315
[TBL] [Abstract][Full Text] [Related]
8. [Acute arterial thrombosis of the extremity in pseudoxanthoma elasticum].
Rodríguez-Camarero SJ; Manchado P; González JA; Castro MA; Rodero JI; Mateo AM
Angiologia; 1992; 44(2):58-61. PubMed ID: 1626728
[TBL] [Abstract][Full Text] [Related]
9. [Comparison of side effects caused by intra-arterial and intravenous infusion of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) for urothelial cancer].
Uchida J; Okada H; Ohguchi N; Kawa G; Koyama Y; Mikami O; Kawamura H; Ohhara T; Matsuda T
Hinyokika Kiyo; 1997 Sep; 43(9):637-40. PubMed ID: 9365842
[TBL] [Abstract][Full Text] [Related]
10. [Arterial thrombosis in a patient after chemotherapy (BEP protocol) for extra-gonadal dysgerminoma].
Schmidt J; Zenut M; De Marquilly F; Maciejewski C; Plagne R; Lavarenne J
Therapie; 1995; 50(5):476-8. PubMed ID: 8571294
[No Abstract] [Full Text] [Related]
11. [Clinical evaluation of M-VAC (methotrexate, vinblastine, adriamycin and cisplatin) chemotherapy for advanced urothelial cancer].
Mikami K; Nakagawa S; Takada H; Ebisui K; Sugimoto K; Watanabe H; Maegawa M; Nakao M
Hinyokika Kiyo; 1994 Apr; 40(4):303-7. PubMed ID: 8191968
[TBL] [Abstract][Full Text] [Related]
12. Phase III comparison of methotrexate, vinblastine, doxorubicin, and cisplatin (MVAC) vs. doxorubicin and cisplatin (AC) in women with advanced primary or recurrent metastatic carcinoma of the uterine endometrium.
Long HJ; Nelimark RA; Podratz KC; Suman V; Keeney GL; Nikcevich DA; Kugler JW; Rowland KM; Kardinal CG; Wos EJ
Gynecol Oncol; 2006 Mar; 100(3):501-5. PubMed ID: 16185755
[TBL] [Abstract][Full Text] [Related]
13. Acute arterial thrombosis following chemotherapy in a patient with a gastric carcinoma.
Doganci S; Kadan M; Kaya E; Erol G; Gunay C; Demirkilic U
Cardiovasc J Afr; 2013 Mar; 24(2):e7-9. PubMed ID: 23613003
[TBL] [Abstract][Full Text] [Related]
14. [Chemotherapy-induced thrombotic occlusion of mesenteric arteries--case report and review of the literature].
Okamoto T; Noguchi Y; Yoshikawa T; Nomura K; Fukuzawa K; Uranaka Y; Makino T; Tsuburaya A; Amano T; Matsumoto A
Gan To Kagaku Ryoho; 1994 Jul; 21(8):1279-82. PubMed ID: 8031173
[TBL] [Abstract][Full Text] [Related]
15. Proton beam therapy for invasive bladder cancer: a prospective study of bladder-preserving therapy with combined radiotherapy and intra-arterial chemotherapy.
Hata M; Miyanaga N; Tokuuye K; Saida Y; Ohara K; Sugahara S; Kagei K; Igaki H; Hashimoto T; Hattori K; Shimazui T; Akaza H; Akine Y
Int J Radiat Oncol Biol Phys; 2006 Apr; 64(5):1371-9. PubMed ID: 16580495
[TBL] [Abstract][Full Text] [Related]
16. Impact of recombinant human granulocyte colony stimulating factor on dose intensity and toxicity of three cycles of methotrexate, vinblastine, doxorubicin and cisplatin in patients with previously untreated urothelial bladder carcinoma.
Viens P; Gravis G; Bladou F; Lechevallier E; Baume D; Camerlo J; Cowen D; Coulange C; Serment G; Resbeut M; Maraninchi D
Eur Cytokine Netw; 1996 Sep; 7(3):395-9. PubMed ID: 8954183
[TBL] [Abstract][Full Text] [Related]
17. Methotrexate, vinblastine, adriamycin and cisplatin (MVAC) chemotherapy for the treatment of advanced bladder carcinoma.
Balbay MD; Ozen H; Uluçay S; Sahin A; Ergen A; Koçal C; Remzi D
Int Urol Nephrol; 1993; 25(4):351-7. PubMed ID: 8276565
[TBL] [Abstract][Full Text] [Related]
18. Chemotherapy for genitourinary malignancies: a few victories, more promises, and a lot of unfinished business.
Roth BJ
Semin Urol Oncol; 2001 Aug; 19(3):155-6. PubMed ID: 11561981
[No Abstract] [Full Text] [Related]
19. [A case of anaphylactic shock induced by pirarubicin hydrochloride].
Mitsuhashi M; Iwata H; Kiyota A; Kamizuru M; Nakatani T
Hinyokika Kiyo; 2004 Apr; 50(4):257-9. PubMed ID: 15188619
[TBL] [Abstract][Full Text] [Related]
20. A dose-seeking trial of edatrexate in combination with vinblastine, adriamycin, cisplatin, and filgrastim (EVAC/G-CSF) in patients with advanced malignancies: promising antineoplastic activity against non-small cell lung carcinomas.
Colón-Otero G; Marschke R; Camoriano JK; Sorensen JM; Sloan JA; Richardson RL
Cancer J Sci Am; 1997; 3(5):297-302. PubMed ID: 9327154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
